文献速递脑血管病外科神经重症

支架辅助弹簧圈栓塞治疗宽颈破裂脑动脉瘤:日本神经血管内治疗注册研究4观察性调查

Stent-Assisted Coiling for Wide-Neck Ruptured Cerebral Aneurysms: An Observational Survey of Data from the Japanese Registry of Neuroendovascular Therapy 4.
PubMed 文献 · World Neurosurg · 2025-11-20

该研究基于日本神经血管内治疗注册研究4(2015–2019年)数据,回顾性分析3083例破裂宽颈脑动脉瘤在蛛网膜下腔出血后14天内行瘤内栓塞的病例。比较支架辅助弹簧圈栓塞(SAC)与非SAC组的30天良好临床结局、24小时内出血并发症、动脉瘤再出血及血栓栓塞事件(TEs)。结果显示两组30天良好临床结局无显著差异,SAC组TEs发生率显著更高(13.0% vs. 8.5%,p=0.004);亚组分析表明非术前启动双联抗血小板治疗是SAC术中TEs的独立预测因素(调整OR 2.39,95%CI 1.11–5.47,p=0.026)。结论认为SAC用于破裂脑动脉瘤具有可行性,术前抗血小板治疗是克服TEs的重要因素。

要点

  • SAC与非SAC组30天良好临床结局无显著差异(p=0.303)。
  • SAC组血栓栓塞事件发生率显著高于非SAC组(13.0% vs. 8.5%,p=0.004)。
  • 非术前启动双联抗血小板治疗是SAC术中TEs的独立预测因素(调整OR 2.39)。

核心结论

  • SAC治疗破裂宽颈脑动脉瘤的30天临床结局与非SAC相当,提示其可行性。
  • 术前抗血小板治疗是克服SAC相关血栓栓塞事件的重要因素。

研究设计与样本

  • 回顾性分析日本神经血管内治疗注册研究4(2015–2019年)数据。
  • 纳入蛛网膜下腔出血后14天内行瘤内栓塞的破裂宽颈脑动脉瘤病例,共3083例手术。
  • 比较SAC与非SAC组的30天良好临床结局、24小时内出血并发症、动脉瘤再出血及血栓栓塞事件。
  • 亚组分析探讨SAC术后术中血栓栓塞事件的危险因素。

主要发现

  • 单因素分析显示SAC与非SAC组30天良好临床结局率无显著差异(p=0.303)。
  • 两组24小时内出血并发症率(p=0.396)和动脉瘤再出血率(p=0.793)无显著差异。
  • SAC组血栓栓塞事件率显著高于非SAC组(13.0% vs. 8.5%,p=0.004)。
  • 亚组分析显示非术前启动双联抗血小板治疗是SAC术中血栓栓塞事件的独立预测因素(调整OR 2.39,95%CI 1.11–5.47,p=0.026)。

临床怎么用

  • 对于破裂宽颈脑动脉瘤,SAC可作为治疗选择之一,但需警惕血栓栓塞事件风险。
  • SAC术前启动双联抗血小板治疗可能降低术中血栓栓塞事件风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The safety and efficacy of stent-assisted coiling (SAC) in ruptured cerebral aneurysms remain controversial. The aim of this study was to assess the feasibility of using SAC for the treatment of ruptured wide-neck aneurysms in Japan. METHODS: We retrospectively analyzed data from the Japanese Registry of Neuroendovascular Therapy 4 from 2015 to 2019. Data on intra-aneurysmal embolization for ruptured wide-neck aneurysms within 14 days of subarachnoid hemorrhage onset were extracted. The incidence of favorable clinical outcomes at 30 days, hemorrhagic complications within 24 hours, aneurysmal rebleeding, and thromboembolic events (TEs) were compared between the SAC and non-SAC groups. A subgroup analysis was performed to clarify the risk factors for intraprocedural TEs in patients after SAC. RESULTS: In the univariate analysis of 3083 procedures, no significant difference in the rate of favorable clinical outcomes was noted between the SAC and non-SAC groups (p=0.303). No significant differences in the rates of hemorrhagic complications within 24 h (p=0.396) and aneurysmal rebleeding (p=0.793) were found between the 2 groups, whereas the TE rate was significantly higher in the SAC group than in the non-SAC group (13.0% vs. 8.5%, p=0.004). The subgroup analysis revealed that non preoperative initiation of dual antiplatelet therapy was an independent predictor of intraprocedural TEs in SAC (adjusted odds ratio: 2.39, 95% confidence interval: 1.11-5.47, p=0.026). CONCLUSIONS: The 30-day clinical outcomes were comparable between both groups, suggesting the feasibility of SAC for ruptured cerebral aneurysms. Preoperative antiplatelet therapy is an important factor for overcoming TEs.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ogura T, Imamura H, Sakai N, et al. Stent-Assisted Coiling for Wide-Neck Ruptured Cerebral Aneurysms: An Observational Survey of Data from the Japanese Registry of Neuroendovascular Therapy 4. World Neurosurg. 2025. PMID: 41274653. doi:10.1016/j.wneu.2025.124653

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。